Trial Profile
A Phase 1 Study Consisting of a Double-Blind, Placebo Controlled Multiple Dose Study of TRx0037 in Healthy Elderly Volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 13 Dec 2010
Price :
$35
*
At a glance
- Drugs TRx 0037 (Primary)
- Indications Alzheimer's disease
- Focus Adverse reactions; Pharmacokinetics
- 13 Dec 2010 New trial record